Tulathromycin is a?macrolide antibiotic?used to treat?bovine respiratory disease?(BRD) in cattle and?swine respiratory disease?in pigs.
This report aims to provide a comprehensive presentation of the global market for Tulathromycin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tulathromycin. This report contains market size and forecasts of Tulathromycin in global, including the following market information:
Global Tulathromycin Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Tulathromycin market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
>99% Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Tulathromycin include Zhejiang Genebest Pharmaceutical, AVF Chemical Industrial, Rochem, Livzon Group Fuzhou Fuxing Pharmaceutical Co.,Ltd, Hubei Honch Pharmaceutical Co.,ltd, Hubei Weideli Chemical Science and Technology Co., Ltd, Zoetis and Wuhan Kemick Biomedical Technology Co., Ltd, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Tulathromycin companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Tulathromycin Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Tulathromycin Market Segment Percentages, by Type, 2022 (%)
>99%
98%-99%
Global Tulathromycin Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Tulathromycin Market Segment Percentages, by Application, 2022 (%)
Pig
Cattle
Global Tulathromycin Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Tulathromycin Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Tulathromycin revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Tulathromycin revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Zhejiang Genebest Pharmaceutical
AVF Chemical Industrial
Rochem
Livzon Group Fuzhou Fuxing Pharmaceutical Co.,Ltd
Hubei Honch Pharmaceutical Co.,ltd
Hubei Weideli Chemical Science and Technology Co., Ltd
Zoetis
Wuhan Kemick Biomedical Technology Co., Ltd
Outline of Major Chapters:
Chapter 1: Introduces the definition of Tulathromycin, market overview.
Chapter 2: Global Tulathromycin market size in revenue.
Chapter 3: Detailed analysis of Tulathromycin company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Tulathromycin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Tulathromycin Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Tulathromycin Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Tulathromycin Overall Market Size
2.1 Global Tulathromycin Market Size: 2022 VS 2030
2.2 Global Tulathromycin Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Tulathromycin Players in Global Market
3.2 Top Global Tulathromycin Companies Ranked by Revenue
3.3 Global Tulathromycin Revenue by Companies
3.4 Top 3 and Top 5 Tulathromycin Companies in Global Market, by Revenue in 2022
3.5 Global Companies Tulathromycin Product Type
3.6 Tier 1, Tier 2 and Tier 3 Tulathromycin Players in Global Market
3.6.1 List of Global Tier 1 Tulathromycin Companies
3.6.2 List of Global Tier 2 and Tier 3 Tulathromycin Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Tulathromycin Market Size Markets, 2022 & 2030
4.1.2 >99%
4.1.3 98%-99%
4.2 By Type - Global Tulathromycin Revenue & Forecasts
4.2.1 By Type - Global Tulathromycin Revenue, 2018-2023
4.2.2 By Type - Global Tulathromycin Revenue, 2024-2030
4.2.3 By Type - Global Tulathromycin Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Tulathromycin Market Size, 2022 & 2030
5.1.2 Pig
5.1.3 Cattle
5.2 By Application - Global Tulathromycin Revenue & Forecasts
5.2.1 By Application - Global Tulathromycin Revenue, 2018-2023
5.2.2 By Application - Global Tulathromycin Revenue, 2024-2030
5.2.3 By Application - Global Tulathromycin Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Tulathromycin Market Size, 2022 & 2030
6.2 By Region - Global Tulathromycin Revenue & Forecasts
6.2.1 By Region - Global Tulathromycin Revenue, 2018-2023
6.2.2 By Region - Global Tulathromycin Revenue, 2024-2030
6.2.3 By Region - Global Tulathromycin Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Tulathromycin Revenue, 2018-2030
6.3.2 US Tulathromycin Market Size, 2018-2030
6.3.3 Canada Tulathromycin Market Size, 2018-2030
6.3.4 Mexico Tulathromycin Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Tulathromycin Revenue, 2018-2030
6.4.2 Germany Tulathromycin Market Size, 2018-2030
6.4.3 France Tulathromycin Market Size, 2018-2030
6.4.4 U.K. Tulathromycin Market Size, 2018-2030
6.4.5 Italy Tulathromycin Market Size, 2018-2030
6.4.6 Russia Tulathromycin Market Size, 2018-2030
6.4.7 Nordic Countries Tulathromycin Market Size, 2018-2030
6.4.8 Benelux Tulathromycin Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Tulathromycin Revenue, 2018-2030
6.5.2 China Tulathromycin Market Size, 2018-2030
6.5.3 Japan Tulathromycin Market Size, 2018-2030
6.5.4 South Korea Tulathromycin Market Size, 2018-2030
6.5.5 Southeast Asia Tulathromycin Market Size, 2018-2030
6.5.6 India Tulathromycin Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Tulathromycin Revenue, 2018-2030
6.6.2 Brazil Tulathromycin Market Size, 2018-2030
6.6.3 Argentina Tulathromycin Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Tulathromycin Revenue, 2018-2030
6.7.2 Turkey Tulathromycin Market Size, 2018-2030
6.7.3 Israel Tulathromycin Market Size, 2018-2030
6.7.4 Saudi Arabia Tulathromycin Market Size, 2018-2030
6.7.5 UAE Tulathromycin Market Size, 2018-2030
7 Tulathromycin Companies Profiles
7.1 Zhejiang Genebest Pharmaceutical
7.1.1 Zhejiang Genebest Pharmaceutical Company Summary
7.1.2 Zhejiang Genebest Pharmaceutical Business Overview
7.1.3 Zhejiang Genebest Pharmaceutical Tulathromycin Major Product Offerings
7.1.4 Zhejiang Genebest Pharmaceutical Tulathromycin Revenue in Global Market (2018-2023)
7.1.5 Zhejiang Genebest Pharmaceutical Key News & Latest Developments
7.2 AVF Chemical Industrial
7.2.1 AVF Chemical Industrial Company Summary
7.2.2 AVF Chemical Industrial Business Overview
7.2.3 AVF Chemical Industrial Tulathromycin Major Product Offerings
7.2.4 AVF Chemical Industrial Tulathromycin Revenue in Global Market (2018-2023)
7.2.5 AVF Chemical Industrial Key News & Latest Developments
7.3 Rochem
7.3.1 Rochem Company Summary
7.3.2 Rochem Business Overview
7.3.3 Rochem Tulathromycin Major Product Offerings
7.3.4 Rochem Tulathromycin Revenue in Global Market (2018-2023)
7.3.5 Rochem Key News & Latest Developments
7.4 Livzon Group Fuzhou Fuxing Pharmaceutical Co.,Ltd
7.4.1 Livzon Group Fuzhou Fuxing Pharmaceutical Co.,Ltd Company Summary
7.4.2 Livzon Group Fuzhou Fuxing Pharmaceutical Co.,Ltd Business Overview
7.4.3 Livzon Group Fuzhou Fuxing Pharmaceutical Co.,Ltd Tulathromycin Major Product Offerings
7.4.4 Livzon Group Fuzhou Fuxing Pharmaceutical Co.,Ltd Tulathromycin Revenue in Global Market (2018-2023)
7.4.5 Livzon Group Fuzhou Fuxing Pharmaceutical Co.,Ltd Key News & Latest Developments
7.5 Hubei Honch Pharmaceutical Co.,ltd
7.5.1 Hubei Honch Pharmaceutical Co.,ltd Company Summary
7.5.2 Hubei Honch Pharmaceutical Co.,ltd Business Overview
7.5.3 Hubei Honch Pharmaceutical Co.,ltd Tulathromycin Major Product Offerings
7.5.4 Hubei Honch Pharmaceutical Co.,ltd Tulathromycin Revenue in Global Market (2018-2023)
7.5.5 Hubei Honch Pharmaceutical Co.,ltd Key News & Latest Developments
7.6 Hubei Weideli Chemical Science and Technology Co., Ltd
7.6.1 Hubei Weideli Chemical Science and Technology Co., Ltd Company Summary
7.6.2 Hubei Weideli Chemical Science and Technology Co., Ltd Business Overview
7.6.3 Hubei Weideli Chemical Science and Technology Co., Ltd Tulathromycin Major Product Offerings
7.6.4 Hubei Weideli Chemical Science and Technology Co., Ltd Tulathromycin Revenue in Global Market (2018-2023)
7.6.5 Hubei Weideli Chemical Science and Technology Co., Ltd Key News & Latest Developments
7.7 Zoetis
7.7.1 Zoetis Company Summary
7.7.2 Zoetis Business Overview
7.7.3 Zoetis Tulathromycin Major Product Offerings
7.7.4 Zoetis Tulathromycin Revenue in Global Market (2018-2023)
7.7.5 Zoetis Key News & Latest Developments
7.8 Wuhan Kemick Biomedical Technology Co., Ltd
7.8.1 Wuhan Kemick Biomedical Technology Co., Ltd Company Summary
7.8.2 Wuhan Kemick Biomedical Technology Co., Ltd Business Overview
7.8.3 Wuhan Kemick Biomedical Technology Co., Ltd Tulathromycin Major Product Offerings
7.8.4 Wuhan Kemick Biomedical Technology Co., Ltd Tulathromycin Revenue in Global Market (2018-2023)
7.8.5 Wuhan Kemick Biomedical Technology Co., Ltd Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Tulathromycin Market Opportunities & Trends in Global Market
Table 2. Tulathromycin Market Drivers in Global Market
Table 3. Tulathromycin Market Restraints in Global Market
Table 4. Key Players of Tulathromycin in Global Market
Table 5. Top Tulathromycin Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Tulathromycin Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Tulathromycin Revenue Share by Companies, 2018-2023
Table 8. Global Companies Tulathromycin Product Type
Table 9. List of Global Tier 1 Tulathromycin Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Tulathromycin Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Tulathromycin Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Tulathromycin Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Tulathromycin Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Tulathromycin Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Tulathromycin Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Tulathromycin Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Tulathromycin Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Tulathromycin Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Tulathromycin Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Tulathromycin Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Tulathromycin Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Tulathromycin Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Tulathromycin Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Tulathromycin Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Tulathromycin Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Tulathromycin Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Tulathromycin Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Tulathromycin Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Tulathromycin Revenue, (US$, Mn), 2024-2030
Table 30. Zhejiang Genebest Pharmaceutical Company Summary
Table 31. Zhejiang Genebest Pharmaceutical Tulathromycin Product Offerings
Table 32. Zhejiang Genebest Pharmaceutical Tulathromycin Revenue (US$, Mn) & (2018-2023)
Table 33. Zhejiang Genebest Pharmaceutical Key News & Latest Developments
Table 34. AVF Chemical Industrial Company Summary
Table 35. AVF Chemical Industrial Tulathromycin Product Offerings
Table 36. AVF Chemical Industrial Tulathromycin Revenue (US$, Mn) & (2018-2023)
Table 37. AVF Chemical Industrial Key News & Latest Developments
Table 38. Rochem Company Summary
Table 39. Rochem Tulathromycin Product Offerings
Table 40. Rochem Tulathromycin Revenue (US$, Mn) & (2018-2023)
Table 41. Rochem Key News & Latest Developments
Table 42. Livzon Group Fuzhou Fuxing Pharmaceutical Co.,Ltd Company Summary
Table 43. Livzon Group Fuzhou Fuxing Pharmaceutical Co.,Ltd Tulathromycin Product Offerings
Table 44. Livzon Group Fuzhou Fuxing Pharmaceutical Co.,Ltd Tulathromycin Revenue (US$, Mn) & (2018-2023)
Table 45. Livzon Group Fuzhou Fuxing Pharmaceutical Co.,Ltd Key News & Latest Developments
Table 46. Hubei Honch Pharmaceutical Co.,ltd Company Summary
Table 47. Hubei Honch Pharmaceutical Co.,ltd Tulathromycin Product Offerings
Table 48. Hubei Honch Pharmaceutical Co.,ltd Tulathromycin Revenue (US$, Mn) & (2018-2023)
Table 49. Hubei Honch Pharmaceutical Co.,ltd Key News & Latest Developments
Table 50. Hubei Weideli Chemical Science and Technology Co., Ltd Company Summary
Table 51. Hubei Weideli Chemical Science and Technology Co., Ltd Tulathromycin Product Offerings
Table 52. Hubei Weideli Chemical Science and Technology Co., Ltd Tulathromycin Revenue (US$, Mn) & (2018-2023)
Table 53. Hubei Weideli Chemical Science and Technology Co., Ltd Key News & Latest Developments
Table 54. Zoetis Company Summary
Table 55. Zoetis Tulathromycin Product Offerings
Table 56. Zoetis Tulathromycin Revenue (US$, Mn) & (2018-2023)
Table 57. Zoetis Key News & Latest Developments
Table 58. Wuhan Kemick Biomedical Technology Co., Ltd Company Summary
Table 59. Wuhan Kemick Biomedical Technology Co., Ltd Tulathromycin Product Offerings
Table 60. Wuhan Kemick Biomedical Technology Co., Ltd Tulathromycin Revenue (US$, Mn) & (2018-2023)
Table 61. Wuhan Kemick Biomedical Technology Co., Ltd Key News & Latest Developments
List of Figures
Figure 1. Tulathromycin Segment by Type in 2022
Figure 2. Tulathromycin Segment by Application in 2022
Figure 3. Global Tulathromycin Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Tulathromycin Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Tulathromycin Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Tulathromycin Revenue in 2022
Figure 8. By Type - Global Tulathromycin Revenue Market Share, 2018-2030
Figure 9. By Application - Global Tulathromycin Revenue Market Share, 2018-2030
Figure 10. By Type - Global Tulathromycin Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Tulathromycin Revenue Market Share, 2018-2030
Figure 12. By Application - Global Tulathromycin Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Tulathromycin Revenue Market Share, 2018-2030
Figure 14. By Region - Global Tulathromycin Revenue Market Share, 2018-2030
Figure 15. By Country - North America Tulathromycin Revenue Market Share, 2018-2030
Figure 16. US Tulathromycin Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Tulathromycin Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Tulathromycin Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Tulathromycin Revenue Market Share, 2018-2030
Figure 20. Germany Tulathromycin Revenue, (US$, Mn), 2018-2030
Figure 21. France Tulathromycin Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Tulathromycin Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Tulathromycin Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Tulathromycin Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Tulathromycin Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Tulathromycin Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Tulathromycin Revenue Market Share, 2018-2030
Figure 28. China Tulathromycin Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Tulathromycin Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Tulathromycin Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Tulathromycin Revenue, (US$, Mn), 2018-2030
Figure 32. India Tulathromycin Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Tulathromycin Revenue Market Share, 2018-2030
Figure 34. Brazil Tulathromycin Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Tulathromycin Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Tulathromycin Revenue Market Share, 2018-2030
Figure 37. Turkey Tulathromycin Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Tulathromycin Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Tulathromycin Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Tulathromycin Revenue, (US$, Mn), 2018-2030
Figure 41. Zhejiang Genebest Pharmaceutical Tulathromycin Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. AVF Chemical Industrial Tulathromycin Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Rochem Tulathromycin Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Livzon Group Fuzhou Fuxing Pharmaceutical Co.,Ltd Tulathromycin Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Hubei Honch Pharmaceutical Co.,ltd Tulathromycin Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Hubei Weideli Chemical Science and Technology Co., Ltd Tulathromycin Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Zoetis Tulathromycin Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Wuhan Kemick Biomedical Technology Co., Ltd Tulathromycin Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
